Skip to main content
Sign In
 

Clinical Trials


The Lilly AMAC Study
​A study to evaluate the efficacy and safety of the subcutaneously administered drug Mirikizumab for the treatment of active ulcerative colitis. 
​The Gilead – DIVERSITY Study A study to evaluate the efficacy and safety of the orally administered drug Filgotinib for the treatment of active Crohn’s disease.​ 

​The REVOLVE Study

​A study to evaluate the efficacy and safety of the orally administered drug Mongersen (GED-0301) for the treatment of active Crohn’s disease.
www.mongersenstudies.com​
PIONEER-CD Study ​A study to evaluate the effectiveness of the CROWN nutritional supplement in improving the intestinal mucosal health status of patients with Crohn’s disease receiving induction anti-TNF therapy (infliximab or adalimumab).
Vedolizumab (Entyvio) Lactation Study ​A study to assess the concentration of vedolizumab in breast milk of lactating women with active ulcerative colitis or Crohn’s disease who are receiving vedolizumab therapeutically.

 

For additional information about clinical trials, please contact: 

Monica Murray

IBD Clinical Trail Coordinator

Phone: 303-724-7875

E-mail: monica.murray@ucdenver.edu​